Share-Based Compensation - Summary of Compensation Costs (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 11 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Profits interests vested - time-based | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Grant Date Fair Value | $ 23,999,330 | $ 4,669,885 | $ 317,958 | $ 316,000 |
| Profits interests vested - performance-based | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Grant Date Fair Value | 103,000 | 65,000 | 15,000 | |
| Profits interests granted - time-based | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Compensation expense | $ 4,635,142 | 3,524,277 | $ 447,475 | $ 474,042 |
| Profits interests granted - performance-based | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Compensation expense | $ 176,975 | |||
| X | ||||||||||
- Definition Fair value at grant date for non-vested equity-based awards granted during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|